“…The outbreak continued to amplify in Brazil, and by 2016, it is estimated that between 200,000 and 1.3 million cases were reported in Brazil, with seroprevalence rates of over 63% [ 8 , 59 , 60 ]. During the peak of the epidemic, in the United States (US), all 49 states along with the District of Columbia reported confirmed cases of ZIKV infection, though most of these cases (4944) were travel-related, with only 224 cases being reported as autochthonous infections [ 61 , 62 , 63 , 64 , 65 ].…”